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Three missense variants of metabolic
syndrome-related genes are associated
with alpha-1 antitrypsin levels
Kazuya Setoh1, Chikashi Terao1, Shigeo Muro2, Takahisa Kawaguchi1, Yasuharu Tabara1, Meiko Takahashi1,
Takeo Nakayama3, Shinji Kosugi4, Akihiro Sekine5, Ryo Yamada6, Michiaki Mishima2 & Fumihiko Matsuda1,6
Alpha-1 antitrypsin (AAT) encoded by SERPINA1 is an acute-phase inﬂammation marker, and
AAT deﬁciency (AATD) is known as one of the common genetic disorders in European
populations. However, no genetic determinants to AAT levels apart from the SERPINA gene
clusters have been identiﬁed to date. Here we perform a genome-wide association study
of serum AAT levels followed by a two-staged replication study recruiting a total of
9,359 Japanese community-dwelling population. Three missense variants of metabolic
syndrome-related genes, namely, rs671 in ALDH2, rs1169288 in HNF1A and rs1260326 in
GCKR, signiﬁcantly associate with AAT levels (Pr1.5 10 12). Previous reports have shown
the functional relevance of ALDH2 and HNF1A to AAT. We observe a signiﬁcant interaction of
rs671 and alcohol consumption on AAT levels. We conﬁrm the association between AATand
rs2896268 in SERPINA1, which is independent of known causative variants of AATD. These
ﬁndings would support various AAT functions including metabolic processes.
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A
lpha-1 antitrypsin (AAT) is an acute-phase inﬂammation
marker synthesized predominantly in hepatocytes and
serves as a protease inhibitor of proteolytic enzymes
including elastase, trypsin, thrombin and bacterial proteases1,2.
Recent studies have revealed the wide range of functions for
AAT3–5. AAT is encoded by the SERPINA1 gene on chromosome
14 (ref. 6). The reduction of AAT levels leads to inﬂammation in
the lung, and is associated with the risk for early-onset chronic
obstructive pulmonary disease (COPD)7–9. AAT deﬁciency
(AATD) is a common genetic disorder among Caucasian
populations caused by mutations in SERPINA1. Patients with
AATD present with emphysema due to imbalance of elastase and
anti-elastase effect of AAT, and, in some cases, accumulating
AAT affects hepatic functions and leads to liver cirrhosis and
hepatocellular carcinoma10,11. Many variants in SERPINA1 were
reported to cause AATD12. The S variant (PI S, rs17580) and the
Z variant (PI Z, rs28929474) are the major missense single-
nucleotide polymorphisms (SNPs) leading to AATD by moderate
and severe decline of AAT levels, respectively, through the
conformational change of the AAT protein and the subsequent
faulty secretion of AAT from hepatocytes12. All other variants
reported to cause AATD are rare variants in SERPINA1 (ref. 12).
Genome-wide association studies (GWAS) have enabled us to
detect susceptibility loci associated with quantitative traits as well
as discrete phenotypes using an unbiased approach. To date, only
one GWAS has been reported in an European population to
detect susceptibility loci to serum AAT levels, and the authors
identiﬁed markers in the SERPINA gene cluster on 14q32.13
(ref. 13). Thus, there are no other markers reported to be
associated with serum AAT levels. Novel susceptibility loci would
uncover mechanisms of AAT metabolism and molecular
networks for regulation of inﬂammatory processes in the lung.
As genetic backgrounds differ between different populations,
GWAS using populations other than European populations
would lead to identify novel susceptibility loci to serum AAT
levels. Here we perform GWAS and a two-staged replication
study of serum AAT levels using 9,359 Japanese healthy
individuals participating in the Nagahama Study and show a
total of three missense variants, rs671, rs1169288 and rs1260326
in metabolic syndrome-related genes, ALDH2, HNF1A and
GCKR, respectively. We also show a signiﬁcant interaction of
rs671 and alcohol consumption on AAT levels. In addition, we
show rs2896268 in SERPINA1 as an AAT-associated variant
independent of known causative variants of AATD.
Results
GWAS of serum AAT levels. We conducted genome scanning
using 3,693 participants of the Nagahama Study, a prospective
Japanese cohort of community-dwelling population14, with the
use of Illumina Inﬁnium arrays to identify genetic loci affecting
serum AAT levels in the Japanese population. The serum AAT
levels did not show a deviated distribution (Supplementary
Fig. 1). We used generalized linear regression model (GLM) with
covariates including age, sex, body-mass index (BMI), C-reative
protein (CRP), the recruiting years and smoking status (for
details, see Methods). We performed genotype imputation by
using the East Asian panel in the 1000 Genome Project15 as a
reference. After quality control, 3,294 subjects and 6,569,727
SNPs were used for the association study (Table 1, for details, see
Methods and Supplementary Figs 2 and 3). The quantile-quantile
plots of the results of the genome scanning revealed no
population structure in the current study (genomic inﬂation
factor l¼ 1.01, Fig. 1a). Thus, we did not apply genomic
control16 into the association study. As a result, rs671 in ALDH2
on chromosome 12 showed a signiﬁcant association beyond the
GWAS signiﬁcant level (GLM P¼ 3.4 10 11, Fig. 1a and
Table 2). Three additional loci, namely, the HNF1A and KSR2
regions on chromosome 12 and the GCKR region on
chromosome 2 showed suggestive associations with P values
less than 1.0 10 6 (GLM P¼ 8.5 10 8, 9.8 10 7 and
7.1 10 7, respectively, Fig. 1a and Table 2). All SNPs showing
P values less than 1.0 10 6 are shown in Supplementary
Table 1. rs1169288 on HNF1A and rs11068574 on KSR2 were 9.2
and 5.8Mbp apart from rs671, respectively, and not in linkage
disequilibrium (LD) with rs671 (r2r0.002, Supplementary
Fig. 4). We conﬁrmed that these two associations were
independent from rs671 by conditioning on rs671 (GLM
Po2.0 10 6, Fig. 1b). When we conditioned the associations
in the four regions by each SNP (rs671, rs1169288, rs11068574
and rs1260326), no further association signals remained
(GLM PZ0.0072, Supplementary Fig. 5). Thus, we selected
these four markers to be genotyped in the replication studies as
candidate markers affecting serum AAT levels.
Two replication studies and combined study. We conducted a
replication study to genotype these four SNPs using 4,023 subjects
in the Nagahama Study by Taqman assay (Table 1 and
Supplementary Fig. 2). As a result, the associations between
serum AAT levels and rs671, rs1169288 or rs1260326 were
replicated with P values less than 2.7 10 4 (GLM P¼ 2.2
 10 10, 2.7 10 4 and 2.3 10 7, respectively, Table 2). The
association between rs11068574 and serum AAT levels was not
replicated (GLM P¼ 0.22, Table 2).
We further performed a second replication for these
SNPs using 2,042 subjects by Taqman assay (Table 1 and
Supplementary Fig. 2). As a result, the associations of rs671,
rs1169288 or rs1260326 were again replicated and the
overall associations in the combined study were beyond the
GWAS signiﬁcant level (GLM P¼ 2.2 10 23, 1.5 10 12 and
3.1 10 16, respectively, Table 2 and Supplementary Fig. 6A–C).
The association of rs11068574 was again not replicated (GLM
P¼ 0.093, Table 2). All of the SNPs showed success rates of more
than 0.96 and did not show departure from Hardy–Weinberg
Equilibrium in each of the three studies (w2-test PZ0.0019) and
the combined study (w2-test PZ0.045).
Explained effects by the combination of the signiﬁcant SNPs.
All of the three markers showing signiﬁcant associations are
located in exonic regions of the genes and induce amino-acid
alterations of the proteins (Fig. 2 and Table 2). We did not ﬁnd
heterogeneity between GWAS results and replication results
for these three markers (Cochran’s Q test PZ0.14). When we
evaluated interactions between any pairs of these three SNPs,
we did not ﬁnd strong interactions on serum AAT levels
(GLM PZ0.038). When we analysed the association between the
number of susceptibility alleles of these three SNPs and serum
AAT levels using GLM, the association showed a P value of
1.5 10 48 (Supplementary Fig. 6D). These three SNPs were
evaluated to explain 1.95% of total variance of the serum AAT
levels (Supplementary Table 2).
Functional annotation search for causative SNPs. We picked up
all of the variants in strong LD (r240.8) with the three SNPs
and performed functional annotation search of these SNPs by
HaploReg17 (Supplemetary Table 3). None of the other missense
mutations in the three genes were in LD with the three SNPs. The
block of the ﬁve SNPs in strong LD with rs671 included ACAD10
and BRAP as well as ALDH2 (Supplementary Fig. 5 and
Supplementary Table 3). ALDH2 was the only gene among the
three genes in the region whose functional relevance to AAT was
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reported18,19 and which contained SNPs with functional
annotations in hepatic cells (Supplementary Table 3). HNF1A
was shown to be an important expression regulator of AAT20,
and the two SNPs in strong LD with rs1169288 also resided in the
HNF1A locus. The block of the 14 SNPs in strong LD with
rs1260326 contained only the GCKR locus and was more than
46.5 kbp away from the adjacent gene, C2orf16 (Supplementary
Table 3 and Fig. 2). Thus, it is reasonable to regard ALDH2,
HNF1A and GCKR as the responsible genes for the ssociations
with levels of AAT. Notably, all of the three genes are expressed in
the liver and are reported to be associated with metabolic
phenotypes including impairment of insulin secretion21, lipid
proﬁles22,23, risk of type 2 diabetes mellitus24 and cardiovascular
diseases25 and metabolic syndrome pathway26.
Analysis of HNF1A and GCKR conservations. While the
functional importance of amino-acid alteration of ALDH2 by
rs671 is well established (described later), functional impacts of
amino-acid alteration by rs1169288 and rs1260326 on HNF1A
and GCKR are not fully known except for some reports27.
Polyphen-2 software28 did not suggest deleterious change brought
about by the two SNPs. Thus, we analysed conservation of these
amino-acid residues across vertebrates. As a result, isoleucine
altered by rs1169288 was highly conserved in vertebrates
(Supplementary Table 4), supporting the impact of rs1169288.
Proline induced by rs1260326 rather than leucine was conserved
among vertebrates (Supplementary Table 4), suggesting the
importance of the C allele of rs1260326.
Exclusion of possibility of confounded by CRP. It might be
noted that HNF1A and GCKR are known susceptibility loci to
CRP levels26, which are correlated with the levels of AAT.
We conﬁrmed no association between the residuals of AAT
and serum CRP levels, indicating that the associations in these
Table 1 | The characteristics of study subjects.
GWAS Replication 1 Replication 2
Number 3,294 4,023 2,042
Sex (female ratio) (%) 66.5 67.0 68.8
Age* (year) 52.3±14.1 55.3±12.6 53.1±12.9
AAT* (mgdl 1) 133.0±19.4 128.5±17.6 135.4±19.0
BMI* (kgm 2) 22.3±3.2 22.3±3.3 22.3±3.3
Brinkman index* 164.6±319.8 167.2±325.5 149.4±307.6
Alcohol intakew (heavy/moderate/mild) 713/377/2,204 959/379/2,685 466/199/1,377
High-sensitive CRP* (ngml 1) 922.1±3261 937.6±4108 786.5±2548
AAT, Alpha-1 antitrypsin; BMI, body mass index; CRP, C-reactive protein; GWAS, genome-wide association studies.
*The mean±s.d.
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Figure 1 | The results of GWAS on the serum AAT levels (n¼3,294). (a) The quantile-quantile plots (left) and the Manhattan plot for the genome-wide
scanning: The horizontal line indicates the genome-wide signiﬁcant level, P¼ 5.0 108. (b) The regional plot for a part of chromosome 12 for
nominal (left) and conditional (right) associations adjusted for rs671 genotypes. P values were calculated by generalized linear regression model.
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two regions were not dependent on the associations between
CRP levels and the two regions (GLM P¼ 1.0, Supplementary
Fig. 7).
Expression correlations between SERPINA1 and the three genes.
We analysed whether these three gene expressions are associated
with expressions of SERPINA1 using gene expression database in
the Japanese population29 to infer the relationship between AAT
and the three proteins encoded by these three genes. As a result,
the expressions of ALDH2, GCKR and HNF1A were signiﬁcantly
associated with that of SERPINA1 or the transcript variant of
SERPINA1 (Student’s t distribution test P¼ 5.6 10 15,
Spearman’s rank sum coefﬁcient (rs) ¼ 0.43, P¼ 3.7 10 6,
rs¼ 0.26 and P¼ 1.7 10 8, rs¼ 0.31, respectively, Supplementary
Fig. 8). These results may suggest a molecular network among
these genes and support the association between AAT and GCKR
as well as those between AAT and ALDH2 or HNF1A.
Detailed analysis of ALDH2. Next, we concentrated on the
associations observed in ALDH2, the most signiﬁcant locus with
previously reported functional analyses. ALDH2 dehydrogenates
acetaldehyde that is produced by various processes and inhibits
the anti-elastase activity of AAT19. As ethanol is dehydrogenated
into acetaldehyde, ALDH2 is also involved with alcohol
consumption. The A allele of rs671 is known to decrease
ALDH2 activity and lower alcohol tolerance18,23,30. In fact, rs671
is very strongly associated with alcohol consumption in the
current study (Student’s t distribution test P¼ 2.2 10 248).
As alcohol consumption is known to affect AAT levels
presumably via acetaldehyde31, the association of ALDH2 might
be explained by altering alcohol consumption due to rs671. In
fact, conditioning on alcohol consumption greatly diminished the
association of rs671 (after conditioned; GLM P¼ 9.2 10 8).
We still found a substantial association after conditioning,
suggesting further mechanisms aside from altering alcohol
drinking by rs671. In contrast, conditioning on alcohol did
not alter the associations of rs1260326 and rs1169288
(GLM P¼ 3.0 10 16 and 6.6 10 12, respectively). We also
conﬁrmed that no novel susceptibility markers appeared in
GWAS using alcohol consumption as an additional covariate.
Interaction between rs671 in ALDH2 and alcohol consumption.
As rs671 has interactive effects with alcohol consumption on
phenotypes including metabolic trait32,33, we hypothesized that
rs671 and alcohol would show an interactive effect on serum
AAT levels as well. As a result, we identiﬁed a signiﬁcant
interaction between rs671 genotypes and alcohol intake (GLM
P¼ 2.2 10 4, Fig. 3). rs671 A allele showed a trend of increase
in its effect on AAT in those who were heavily drunk (Fig. 3). The
results of other interactions are shown in Supplementary Table 5.
While we also found an interaction between rs671 and smoking
(GLM P¼ 6.8 10 4, Supplementary Table 5 and Supplementary
Fig. 9), this seems to be explained by strong correlation
between alcohol consumption and smoking (rs¼ 0.41, Student’s
t distribution test P¼ 7.2 10 380). In fact, when the interaction
between rs671 and smoking was evaluated by conditioning on the
interaction between rs671 and alcohol intake, the effect was not
Table 2 | Association studies on AAT serum level in the Nagahama Study.




GWAS (N¼ 3,294) Replication 1 (N¼4,023) Replication 2 (N¼2,042) Combined (N¼9,359)
VAF Effect (s.e.) P VAF Effect (s.e.) P VAF Effect (s.e.) P VAF Effect (s.e.) P
rs1260326 2 27730940 GCKR T/C L256P 0.425 2.15 (0.43) 7.1 10 7 0.438 1.84 (0.36) 2.3 10 7 0.430 2.27 (0.58) 9.6 10 5 0.432 2.05 (0.25) 3.1 10 16
rs671 12 112241766 ALDH2 G/A E364K 0.270 3.28 (0.49) 3.4 10 11 0.269 2.55 (0.40) 2.2 10 10 0.267 2.65 (0.65) 4.4 10 5 0.269 2.83 (0.28) 2.2 10 23
rs11068574 12 118053982 KSR2 A/G — 0.651 2.28 (0.46) 9.8 10 7 0.650 0.48 (0.38) 0.22 0.667  1.01 (0.60) 0.093 0.654 0.76 (0.27) 4.3 10 3
rs1169288 12 121416650 HNF1A A/C I27L 0.490 2.40 (0.45) 8.5 108 0.479 1.29 (0.35) 2.7 104 0.503 1.83 (0.58) 1.5 10 3 0.487 1.79 (0.25) 1.5 10 12
AA alteration, amino-acid alteration; AAT, alpha1-antitrypsin, Chr, chromosome, GWAS, genome-wide association study, P, P-value calculated by generalized linear regression model; ref/var, reference
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Figure 2 | Regional plots of the three regions signiﬁcantly associated with the serum AAT levels. The chromosomal positions and P values for SNPs in
the three signiﬁcant regions are shown accordingly. Brightness of the red colour in LD blocks corresponds to the strength of LD. The red stars in the lower
panels represent the associations in the combined study (n¼9,359).
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signiﬁcant (GLM P¼ 0.16). When we assessed the interactions
between rs1260326 in GCKR or rs1169288 in HNF1A and
alcohol or smoking, no signiﬁcant interactions were observed
(Supplementary Table 6).
Association between FEV1.0 and the three SNPs. Next, we
evaluated whether these genetic components associated with AAT
levels in the current study are associated with lung function alone
or in combination because patients with AATD presented
with COPD in their youth. At ﬁrst, we did not ﬁnd a signiﬁcant
association between serum AAT levels and FEV1.0
(Supplementary Fig. 10a). While rs1260326 and rs1169288 did
not show signiﬁcant associations with FEV1.0, rs671 showed a
negative association with FEV1.0 (GLM P¼ 4.5 10 5,
Supplementary Fig. 10b). We observed this association even
after conditioning for AAT levels (GLM P¼ 6.1 10 5,
Supplementary Fig. 11a), suggesting the association of ALDH2
unrelated to AAT. Therefore, the sum of susceptibility alleles of
these three SNPs showing a suggestive negative association with
FEV1.0 can be explained by the negative association of rs671
(GLM P¼ 0.0063 and 0.0086, before and after conditioning on
AAT, Supplementary Figs 10C and 11B). As smoking has a big
impact on the development of COPD in patients with AATD34,
we evaluated the association between FEV1.0 and rs671 based
on smoking status. The negative association was found
to be observed mainly in the non-smoking population
(GLM P¼ 8.1 10 5, Supplementary Fig. 12).
Comparison of associated SNPs between Japanese and Europeans.
Finally, to evaluate the SNPs signiﬁcantly associated with the
serum AAT level in the European population, we searched the
effects in the current study of the 14 SNPs whose signiﬁcant or
suggestive associations were reported in the European GWAS.
Nine out of the 14 SNPs, including rs17580 (PI S) and rs28929474
(PI Z), showed no or very small minor allele frequencies (minor
allele frequency (MAF)r0.006). The results of the remaining ﬁve
SNPs are shown in Table 3. Although rs2896268 showed an
association with the comparable effect size to the European
study(GLM P¼ 2.4 10 4, Table 3), the other four markers did
not show a trend of association in spite of high minor allele
frequencies (GLM PZ0.42, MAFZ0.31, Table 3).
Discussion
The current GWAS and the following two-staged replication
study identiﬁed a total of three missense SNPs signiﬁcantly
associated with serum AAT levels in the ALDH2 and HNF1A loci
on chromosome 12 and the GCKR locus on chromosome 2.
ALDH2 and HNF1A have been reported to be functionally
associated with AAT. Signiﬁcant correlations of gene expression
between SERPINA1 and all of the three genes support functional
relevance of these genes to AAT.
While the SNPs in LD with rs671 contained two other genes
and BRAP was associated with metabolic syndrome35 as well as
ALDH2, the deleterious effect of rs671, the strongest association
of the ALDH2 region and the functional involvement of ALDH2
Table 3 | The associations between SNPs reported in the European GWAS and serum AAT levels in the Japanese population.
SNP Chr Position Gene Ref/var Location The European study The current study
N VAF Effect P N VAF Effect P
rs2736887 14 94812980 SERPINA2A/
SERPINA6
G/C Intergenic 1,392 0.185 7.1 2.5 10 13 3,294 0.576 0.34 0.44
rs926144 14 94813402 SERPINA2A/
SERPINA6
A/G Intergenic 1,392 0.186 7.1 2.7 10 13 3,294 0.549 0.29 0.51
rs4905179 14 94795492 SERPINA6 A/G Upstream 1,392 0.180 6.8 1.2 10 12 3,294 0.476 0.35 0.42
rs11621961 14 94769476 SERPINA6 C/T Downstream 1,392 0.355 5.2 1.4 10 11 3,294 0.310 0.37 0.44
rs2896268 14 94865708 SERPINA1 A/C Upstream 5,569 0.495 1.3 4.1 10 5 3,294 0.502 1.61 2.4 104
Chr, chromosome; N, number of subjects; P, P value calculated by generalized linear regression model; ref/var: reference allele/variant allele; VAF, variant allele frequency.
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Figure 3 | The interaction between the rs671 genotypes and alcohol drinking on the serum AAT levels. The effects of rs671 on serum AAT levels in
linear regression analysis are shown in the groups subdivided into three groups based on alcohol intake. Error bars represent standard errors.
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with AAT activity suggest ALDH2 as a responsible gene. rs671 is
known to strongly affect alcohol consumption by making people
get drunk easily and be light drinkers through decreasing ALDH2
activity23,30. The decrease of ALDH2 activity is attributed to the
impaired binding afﬁnity to coenzyme, NADþ (ref. 36) and
triggers the facial ﬂushing caused by alcohol intake37,38 and local
inﬂammatory diseases39–41. The heterozygous rs671 shows 6%
of the normal activity, and homozygous variant shows
almost negative activity18. Although the alteration of alcohol
consumption by rs671 seemed to explain more than half of the
association in the ALDH2 region, the substantial association
remained after conditioning on alcohol consumption. The
signiﬁcant interaction between rs671 and alcohol intake
revealed the stronger association of rs671 in heavy drinkers.
Functional annotation analysis revealed DNaseI hypersensitivity
site (DHS) and enhancer activity in liver-derived cells at
rs4646776 in intron 8 of ALDH2, in almost complete LD with
rs671 (Supplementary Table 3). Thus, (1) alteration of alcohol
consumption by rs671, (2) interaction between rs671 and alcohol
consumption and (3) potential transcriptional alteration of
ALDH2 induced by a haplotype of rs671 and rs4646776 may
explain the association in this region.
While functional importance of rs1169288 on HNF1A protein
is not known and in silico analysis using Polyphen-2 suggests a
benign change brought about by this SNP, conserved search
suggested the importance of this SNP. In fact, rs1169288 has been
reported for its association with impairment of insulin secretion21
and risk of type 2 diabetes mellitus24 and cardiovascular
diseases25 in community-dwelling populations. The functional
annotation search revealed active promoter effects in liver-
derived cells at rs1169288 and the other two SNPs in LD with
rs1169288 (Supplementary Table 3). It also showed DHS and
binding of transcription factor in hepatic cells at rs1169288 and
one of the two SNPs. A conformational or transcriptional
alteration of HNF1A via rs1169288 and/or SNPs in LD with
rs1169288 would lead to modulation of the regulatory effects of
HNF1A on SERPINA1 expression and explain the association in
the HNF1A region.
While in silico analysis using Polyphen-2 did not result in
damaging effect brought about by rs1260326, a recent in vitro
analysis reported that the C allele of rs1260326 leads to increased
glucokinase activity in the liver and resultant increase of
triglyceride and decrease of glucose levels27. Functional search
revealed enhancer activity and DHS in liver-derived cells at
rs1260326 (Supplementary Table 3). It also showed that three
other SNPs in LD with rs1260326 have strong enhancer activity
and transcription factor binding in hepatic cells. rs1260326
was reported to be associated with metabolic traits including
HOMA-IR42, lipid proﬁles22, NAFLD and NASH with ﬁbrosis43.
Conservation of proline across vertebrates may suggest advantage
of increased glucokinase activity and AAT levels. An increased
glucokinase activity and potential transcriptional alteration in the
liver due to rs1260326 and other SNPs in LD with rs1260326
would explain the association between AAT and the GCKR
region.
It should be noted that all of the three genes are associated with
metabolic phenotypes and are expressed in the liver. As AAT is
predominantly produced in the liver, the associations between
these three genes and AAT suggest that these genes modulate
AAT levels mainly in the liver. When we analysed whether the
three SNPs display cis associations with expressions of ALDH2,
GCKR and HNF1A, respectively, or trans associations with
expression of SERPINA1, we did not observe signiﬁcant
associations. Since functional annotation analysis suggested
enhancer activity and/or DHS at the three SNPs and/or variants
in strong LD with the SNPs in liver-derived cells, we might detect
signiﬁcant cis or trans effects of the SNPs in expression data from
liver-derived cells. As the three variants are missense variants of
genes predominantly expressed in the liver in which AAT is
mainly produced, it is also likely that these three SNPs inﬂuence
serum AAT levels through conformational change derived from
amino-acid alterations, especially rs671.
While AAT is an enzyme controlling inﬂammation by
inhibiting proteases like the neutrophil elastase, recent studies
have revealed a broad range of AAT functions including
inﬂammation, apoptosis, cellular senescence, lipid metabolism
and proteostasis. Thus, the associations between AAT and the
three loci related to metabolic phenotypes suggest the
involvement of AAT with the metabolic syndrome-related
pathway beyond its function as an acute inﬂammatory marker.
While patients with AATD present with COPD, we did not
ﬁnd a signiﬁcant association between AAT levels and FEV1.0. In
addition, we did not ﬁnd signiﬁcant associations between FEV1.0
and genotypes except for rs671. As the A allele of rs671 is
associated with increased AAT levels and decreased FEV1.0, the
association between rs671 and FEV1.0 does not match with the
relationship between AATD and COPD. We did not observe a
signiﬁcant positive association between rs671 and FEV1.0 even in
the smoking population (Supplementary Fig. 12). Further
replication study is necessary to conﬁrm the negative association
of rs671 A allele with FEV1.0 independent of AAT. The poor
translation of genetic associations with AAT into lung function
was also observed in the European study13. As lung functions are
ﬁnely regulated by multiple complexed mechanisms including
smoking and systemic or local inﬂammation, alterations of lung
function derived from these three genetic components associated
with serum AAT levels might be limited and difﬁcult to identify.
Another possibility is that serum AAT levels do not precisely
represent AAT levels in the lung. Uncovering mechanisms
regulating AAT levels in the lung and appropriate modelling
for lung AAT levels would lead to elucidation of the importance
of genetic components associated with AAT levels on lung
function.
The three SNPs were not reported in the previous European
GWAS13. As the A allele of rs671 was frequently observed in
Asian populations and is rarely seen in European populations, the
lack of the association between rs671 and AAT in the European
study seems appropriate. In addition, all of the SNPs in strong LD
with rs671 in the Japanese population showed very small allele
frequencies in European population (Supplementary Table 3). In
contrast, rs1169288 and rs1260326 have comparable allele
frequencies in Asians and Europeans (0.539 versus 0.283 and
0.490 versus 0.600, respectively, Hapmap phase II data). There are
several possibilities to explain the discrepancy of the two
associations between the two populations. First, the lack of
power (n¼ 1,392) or overrepresentation of asthmatic patients in
the previous European GWAS may explain the lack of signiﬁcant
associations in the Europeans. Second, there might be other
causative variants that are in LD with the two SNPs that can
speciﬁcally be found in the Japanese and not in the European
population due to the different LD structures between
populations. However, no SNPs in strong LD with the two
SNPs in Japanese showed highly different allele frequencies from
the two SNPs in European population (Supplementary Table 3).
As the two SNPs were associated with multiple phenotypes in
European populations and the functional importance of
rs1169288 was experimentally shown, the ﬁrst possibility seems
more likely. It is reasonable to perform quantitative trait linear
regression analysis of AAT levels in a large-scale healthy
European population.
The four SNPs in the SERPINA gene clusters showing
signiﬁcant associations in the European study, namely,
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rs2736887, rs926144, rs4905179 and rs11621961, did not show
evidence of associations in the current study. As the associations
in the European population were shown to largely depend on PI
Z and PI S and these two variants were not found in the current
participants, the lack of associations of these four SNPs in the
current study seems reasonable. We found a suggestive associa-
tion of rs2896268 with a comparable effect size to the European
population. rs2896268 showed an association independent of PIS
and PIZ in the Europeans, suggesting a common mechanism in
the regulation of SERPINA1 expression beyond ethnicity that is
independent of PI S and PI Z.
As our results showed an association of the Asian-speciﬁc
variant and associations of the common variants in GCKR and
HNF1A with serum AAT levels, further replication studies and
functional experiments recruiting other Asian populations and
Europeans are necessary.
The increase of serum CRP levels is an independent risk factor
of developing metabolic syndrome44, diabetes mellitus45, stroke
and cardiac infarction46, and therefore it is reasonable to quantify
AAT levels in a prospective manner to test AAT as the possible
independent risk factor for metabolic syndrome, diabetes mellitus
or stroke. In addition, Mendelian randomization approach47,48 to
test the association between these three markers and developing
metabolic syndrome, diabetes mellitus or stroke would clarify the
direct or indirect function of AAT beyond acute phase
inﬂammation marker.
Methods
Study subjects. This study was performed as a part of The Nagahama Prospective
Genome Cohort for Comprehensive Human Bioscience (the Nagahama Study)14.
The participants of The Nagahama Study were recruited from the general
population living in Nagahama City, a largely rural city of 125,000 inhabitants in
Shiga Prefecture, located in the centre of Japan. Persons aged 30 to 74 years, living
independently in the community and with no physical impairment or dysfunction,
were enrolled and detailed questionnaires were answered by the participants.
Among 9,804 participants recruited from 2008 to 2010, 9,761 subjects were
registered for our analyses excluding pregnant women (n¼ 43). All study
procedures were approved by the ethics committee of Kyoto University Graduate
School of Medicine and the Nagahama Municipal Review Board. Written informed
consent was obtained from all participants.
Genotyping. Among the total of 9,761 samples, genome scanning was conducted
on 3,693 samples by using one of or combinations of human hap610K quad array
(hap610k), human omni 2.5M-4 array (2.5M-4), human omni 2.5M-8 array,
(2.5M-8) human omni 2.5s array (2.5M-s), human exome (Exome) and human
core exome (CoreExome) (Illumina, San Diego, CA, USA). The detailed
distribution of samples for genome-scanning arrays are shown in Supplementary
Table 7. The remaining 4,023 and 2,042 DNA samples were used for the replication
studies 1 and 2, respectively. The details of sample selection are written in
Supplementary Note 1 and Supplementary Fig. 2. The genotyping of the SNPs in
the replication studies was conducted by TaqMan assay (Applied Biosystems).
Quality control for the genotyping data. In the genome scanning of 3,693
subjects, 57 individuals were excluded with a low call rate less than 0.90, 0.95 and
0.99 in the hap610k, 2.5M-4 and other plat forms, respectively. Seven individuals
were excluded due to outliers from Asian clusters by principal component analysis
with HapMap Phase 2 release 28 JPT data set as reference (EIGENSTRAT ver. 2.0,
Supplementary Fig. 3)49 and a total of 316 subjects were excluded due to high
degrees of kinship (Pi-hat greater than 0.35, PLINK ver. 1.07)50. Nineteen samples
were excluded because they lack information of smoking status.
SNPs with a call rate less than 0.99, MAF below 0.01 or showing departure from
HWE (w2-test Po1.0 10 6) were excluded from the analyses. As a result,
267,882 SNPs remained for the following genotype imputation. The details of these
quality check procedures are shown in Supplementary Fig. 2.
Genotype imputation. Genotype imputation was conducted using a standard
procedure with MACH ver. 1.0.16 software51 using East Asian panel in the 1000
Genome project as a reference. Imputed SNPs with MAF below 0.01 or R-square
(RSQ) below 0.3 were removed from the subsequent association analysis. In total,
6,569,727 SNPs were used in the following GWAS on the serum AAT level.
Quantiﬁcation of AAT and CRP levels. The serum levels of AAT and high-
sensitive CRP (hs-CRP) were measured by nephelometry on BN II (R) Nephel-
ometer (Siemens Healthcare Diagnostics, Munchi, Germany) using N-antiserum to
human alpha1-antitrypsin kit and N-latex CRP II kit (the same company),
respectively. These assays were performed at SRL Laboratories (Tokyo, Japan) and
were commercially available. The intra- and inter- assay coefﬁcients of variation of
the AAT levels were 1.07–1.67% and 1.02–1.31%, respectively.
Evaluation of LD. LD between markers were evaluated by PLINK50 software or
Haploview software52.
Heterogeneity of the genetic studies. Heterogeneity among GWAS and the two
replication studies was assessed by Cochran’s Q test for the three SNPs showing
signiﬁcant associations beyond the GWAS signiﬁcant level in the combined study.
Variance explained by the signiﬁcantly associated SNPs. Variance that was
explained by the three SNPs signiﬁcantly associated with AAT levels was calculated
based on the following formula:
V e ¼ E22 1MAFð ÞMAFV tot 1 ð1Þ
Where V_e is an explained variance by an SNP, E is an effect size of the SNP, MAF
is minor allele frequency of the SNP and V_tot is total variance of AAT.
Functional annotation and conservation of amino acids. We used HaploReg17
and analysed whether SNPs in strong LD with the top SNPs have functional effects
including promoter or enhancer activity, DHS and binding of transcription factor.
In silico analysis of assessing effects of amino-acid alteration induced by the
associated markers were performed by Polyphen-2 software28. Conservation of
amino-acid sequences including amino acids altered by the associated markers was
analysed by using UCSC Genome Browser on Human Feb. 2009 (GRCh37/hg19)
Assembly.
Gene expression analysis. The expression data were obtained by the database of
whole peripheral blood in the Japanese population29 (Human Genetic Variation
Browser: http://www.genome.med.kyoto-u.ac.jp/SnpDB/). We used the expression
data of SERPINA1 (Target ID: NM_001002236), a transcriptional variant of
SERPINA1 (SERPINA1_Var) (Target ID: ENST_00000402629), GCKR (Target ID:
NM_001486), ALDH2 (Target ID: NM_000690) and HNF1A (Target ID:
NM_000545). We assessed the correlation between gene expressions by Spearman’s
rank correlation coefﬁcient. The P values for the signiﬁcance of the coefﬁcients
were calculated by Student’s t distribution test. The associations between gene
expressions and genotypes were analysed by generalized linear regression model
adjusted by sex, age, BMI, smoking status, the experimental day and the logarithm
of hs-CRP. The smoking status consists of three categories, namely, never-smoker,
ever-smoker and current-smoker.
The interactions between correlates on the serum AAT level. The interactions
between SNPs were analysed in linear regression model with the use of the same
covariates described in the Statistical analysis section. The interactions between
each of the three SNPs and alcohol consumption consisting of three categories
(Heavy: 43days week 1, Moderate: 2–3days week 1, Mild: o2days week 1)
or Brinkmann index, deﬁned by smoking pack day 1 multiplied by year which
reﬂects the lifetime smoking exposure53, were also analysed. We also analysed
interaction between rs671 and age, sex, BMI or CRP.
Statistical analysis. GWAS and replication studies on the serum AAT levels were
conducted by GLM adjusting for the recruiting year, age, sex, BMI, Brinkman index
and the common logarithm of hs-CRP. These covariates used in the analyses were
selected from non-genetic factors considered in another GWAS report (age, sex
and the smoking status)13 and based on the perceptions on AAT as an acute-phase
inﬂammation marker2. Analysis adding alcohol consumption was also performed.
The cigarette smoking and alcohol consumption history was obtained from the
questionnaire. When we conducted conditional GWAS to ﬁnd other candidate
SNPs associated with serum AAT level independent of each of the associated SNPs,
we added the SNP genotype into the former liner model as a covariate. Correlation
between smoking or rs671 and alcohol consumption was assessed by Spearman’s
rank sum correlation coefﬁcient.
All statistical calculations were conducted using the free software R (http://
www.r-project.org/)54 or PLINK. P values less than 5.0 10 8 were considered to
satisfy the genome-wide signiﬁcance in the combined study. Otherwise, P value less
than 0.05 after Bonferroni’s correction was regarded as signiﬁcant.
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